Status:

NOT_YET_RECRUITING

Improving Outcomes in Early Menopause After Cancer

Lead Sponsor:

Duke University

Conditions:

Early Menopause

Cancer

Eligibility:

FEMALE

18-44 years

Phase:

NA

Brief Summary

The goal of this study is to create and test a new program led by nurse navigators to help women who experience early menopause after cancer. The program includes personalized menopause education, dec...

Eligibility Criteria

Inclusion

  • female (biological sex);
  • 18 to 44 years old;
  • completed cancer treatment (other than endocrine therapy) \>12 months prior to enrollment;
  • have not had a period for more than 12 months (amenorrhea);
  • able to speak and read English.

Exclusion

  • diagnosis of metastatic cancer;
  • visual or hearing impairment that would interfere with participation in study;
  • cognitive impairment or severe mental illness that would interfere with participation in study.

Key Trial Info

Start Date :

April 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2027

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06982677

Start Date

April 1 2026

End Date

March 1 2027

Last Update

June 10 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Improving Outcomes in Early Menopause After Cancer | DecenTrialz